globenewswire

STOCKHOLM, June 07, 2025 (GLOBE NEWSWIRE) -- On June 1st, the "Tea for Harmony - Amazing Guizhou" Guizhou Culture and Tourism Promotion Event in Sweden was successfully held in Stockholm. Chinese Ambassador to Sweden Cui Aimin, Swedish State Secretary for Foreign Affairs Dag Hartelius, Cultural Counsellor of the Chinese Embassy in Sweden, Director of the China Cultural Center in Stockholm Li Rui, and nearly 300 guests from various Swedish circles, overseas Chinese in Sweden, Chinese-funded institutions, and representatives of Chinese students gathered together to embark on a colorful journey to the "Mountain Park Province"

STOCKHOLM, June 07, 2025 (GLOBE NEWSWIRE) -- "Nihao! China" Dragon Boat Festival Garden Party jointly held by China Cultural Center in Stockholm and Culture and Tourism Department of Guizhou Province, successfully concluded at Kungsträdgården, Stockholm, Sweden on May 31st (local time in Sweden). To celebrate the 75th anniversary of the establishment of diplomatic relations between China and Sweden, the Guizhou delegation, who came from afar, includes inheritors of intangible cultural heritage and song and dance troupes, meticulously prepared four immersive cultural experience zones: “Tea for Harmony Yaji Cultural Salon”, “Wonder on Fingertips, Great Beauty of Intangible Heritage”, “Delicious Cuisine in Duanwu, Happy Journey to Explore” and “Gorgeous Ethic Costumes, Beauty and Co-Prosperity”. Distinctive ethnic songs and dances of Guizhou dazzled the audience during the “Conversation and Connection” performance, presenting the unique charm of the “Fascinating Guizhou, A Heaven of Myriad Mountains” in a panoramic way to the Nordic audience, giving a heartfelt cultural tribute to the friendship between China and Sweden.

LEEDS, United Kingdom, June 07, 2025 (GLOBE NEWSWIRE) -- Nimanode, a pioneering protocol building AI-driven autonomous agents on the XRP Ledger (XRPL), has officially launched the presale of its native utility token, $NMA. As the first no-code AI agent builder on XRPL, Nimanode empowers users to deploy, customize, and manage intelligent blockchain agents without writing a single line of code.

GUADALAJARA, Mexico, June 06, 2025 (GLOBE NEWSWIRE) -- Grupo Aeroportuario del Pacífico, S.A.B. de C.V. (NYSE: PAC; BMV: GAP) (“the Company” or “GAP”) announces the conclusion of the ordinary review process for the maximum tariffs per passenger and committed investments included in the Capital Development Program of Montego Bay for the 2026–2030 period.

Washington, DC, June 06, 2025 (GLOBE NEWSWIRE) --

Link to ThinkCareBelieve's Article:  https://thinkcarebelieve.blog/2025/06/06/week-20-week-20-of-americas-comeback-led-by-president-trump/

Complete Incompetence at the Board Level Results in Fire Sale of Treasured MediPharm Asset, the Hope Facility, to a Competitor

U.S.-Made Product Supports General Wellness Goals with a 60-Day Refund Policy

U.S.-Based Supplement Company Integrates Findings from 230+ Scientific Studies to Guide Transparent Wellness Formulations

RIMining launches the most profitable AI cloud mining machine to help cryptocurrency investors make profits faster

Formulated to Support Mental Clarity and Brain Health in Aging Populations

GUADALAJARA, Mexico, June 06, 2025 (GLOBE NEWSWIRE) -- Grupo Aeroportuario del Pacífico, S.A.B. de C.V. (NYSE: PAC; BMV: GAP) (“the Company” or “GAP”) announces the conclusion of the ordinary review process for the maximum tariffs per passenger and committed investments included in the Capital Development Program for Kingston Airport for the 2026–2030 period.

SAN DIEGO, June 06, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Zenas BioPharma, Inc. (NASDAQ: ZBIO) securities pursuant and/or traceable to Zenas BioPharma’s registration statement issued in connection with Zenas BioPharma’s initial public offering (the “IPO”) held on or around September 13, 2024, and were damaged thereby, have until June 16, 2025 to seek appointment as lead plaintiff of the Zenas BioPharma class action lawsuit. Captioned Buathongsri v. Zenas BioPharma, Inc., No. 25-cv-10988 (D. Mass.), the Zenas BioPharma class action lawsuit charges Zenas BioPharma as well as certain of Zenas BioPharma’s top executives and directors, as well as the underwriters of the IPO, with violations of the Securities Act of 1933.